Trial: 202002013

A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients with Advanced Renal Cell Carcinoma with Bone Metastasis (RadiCal)(A031801)

Phase

II (Cancer Prevention)

Principal Investigator

Gay, Hiram

Disease Site

Bones and Joints; Kidney; Metastatic Disease

Learn more about this study at: clinicaltrials.gov